Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ganga Pharmaceuticals Ltd has informed the BSE about the appointment of a new Statutory Auditor for the company. This is a routine regulatory disclosure required under the Companies Act to ensure the company's accounts are audited by a qualified professional. No specific details about the outgoing or incoming auditor, or reasons for the change, have been highlighted in the headline.
This is a standard compliance filing and is unlikely to have any material impact on the stock price or shareholders. Investors should check whether this is part of a routine rotation or signals any governance concerns.